Laumonerie Pierre, Raad Maroun, Tibbo Meagan E, Kerezoudis Panagiotis, Bonnevialle Nicolas, Mansat Pierre
Department of Orthopedic Surgery, Institut Locomoteur, Hôpital Pierre-Paul Riquet, Toulouse, France.
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Shoulder Elbow. 2021 Apr;13(2):205-212. doi: 10.1177/1758573219850111. Epub 2019 May 19.
The EVOLVE implant (Wright Medical Technology, Arlington, TN, USA) is a modular loose-fitting radial head prosthesis. The primary objective was to synthesize all available literature investigating the midterm clinical outcomes of the EVOLVE implant.
An electronic literature search in Pubmed/Medline, Scopus, EMBASE, and Cochrane library was performed querying for studies published in 2000-2017. Articles describing clinical and radiographical outcomes as well as reoperation were included. Outcomes of interest included range of motion, Mayo Elbow Performance Score, Disabilities of the Arm Shoulder and Hand, radiographic outcome, and reason for reoperation.
A total of five articles consisting of 146 patients with EVOLVE implants were included. Mean patient age was 57.4 years (range 22-84), and 43.8% were males (n = 64). Mean follow-up was 4.8 years (range 1-14). Mean Mayo Elbow Performance Score and Disabilities of the Arm Shoulder and Hand score were 87.6 (range 30-100) and 18.9 (range 0-82), respectively. Midterm clinical results were good or excellent (Mayo Elbow Performance Score > 74) in 94 patients. Reoperation was observed in 12 patients, with implant revision required in 2 patients. The primary reason for reoperation was persistent stiffness (n = 9).
Midterm outcomes of EVOLVE radial head prosthesis are satisfactory, and associated complication rates are low. Loose-fit implant method appears to be a reliable approach to avoid failure of radial head prosthesis by painful loosening.
EVOLVE植入物(美国田纳西州阿灵顿市莱特医疗技术公司)是一种模块化的、宽松适配的桡骨头假体。主要目的是综合所有关于EVOLVE植入物中期临床结果的现有文献。
在Pubmed/Medline、Scopus、EMBASE和Cochrane图书馆进行电子文献检索,查询2000 - 2017年发表的研究。纳入描述临床和影像学结果以及再次手术情况的文章。感兴趣的结果包括活动范围、梅奥肘关节功能评分、上肢肩部和手部功能障碍评分、影像学结果以及再次手术的原因。
共纳入5篇文章,涉及146例使用EVOLVE植入物的患者。患者平均年龄为57.4岁(范围22 - 84岁),男性占43.8%(n = 64)。平均随访时间为4.8年(范围1 - 14年)。梅奥肘关节功能评分和上肢肩部和手部功能障碍评分的平均值分别为87.6(范围30 - 100)和18.9(范围0 - 82)。94例患者的中期临床结果为良好或优秀(梅奥肘关节功能评分>74)。12例患者接受了再次手术,其中2例需要更换植入物。再次手术的主要原因是持续僵硬(n = 9)。
EVOLVE桡骨头假体的中期结果令人满意,相关并发症发生率较低。宽松适配的植入方法似乎是一种可靠的方法,可避免桡骨头假体因疼痛性松动而失败。